3D Medicines, Inc. (HK:1244) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3D Medicines Inc. has officially adopted a Chinese name for dual foreign name representation and announced that a new Chinese stock short name will be effective for trading on the Stock Exchange from August 5, 2024. This change is not expected to affect shareholder rights or the company’s operations and finances, and current share certificates will remain valid.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.